Growth Metrics

TransMedics (TMDX) Change in Acquisitions & Divestments (2018 - 2022)

TransMedics has reported Change in Acquisitions & Divestments over the past 4 years, most recently at $28.7 million for Q3 2022.

  • For Q3 2022, Change in Acquisitions & Divestments rose 4.24% year-over-year to $28.7 million; the TTM value through Dec 2022 reached $76.9 million, down 26.61%, while the annual FY2022 figure was $76.9 million, 26.61% down from the prior year.
  • Change in Acquisitions & Divestments for Q3 2022 was $28.7 million at TransMedics, down from $33.8 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $37.8 million in Q2 2021 and troughed at $750000.0 in Q3 2018.
  • A 4-year average of $19.7 million and a median of $18.7 million in 2020 define the central range for Change in Acquisitions & Divestments.
  • On a YoY basis, Change in Acquisitions & Divestments climbed as much as 100.42% in 2021 and fell as far as 38.67% in 2021.
  • Year by year, Change in Acquisitions & Divestments stood at $750000.0 in 2018, then soared by 3922.27% to $30.2 million in 2020, then crashed by 38.67% to $18.5 million in 2021, then skyrocketed by 54.95% to $28.7 million in 2022.
  • Business Quant data shows Change in Acquisitions & Divestments for TMDX at $28.7 million in Q3 2022, $33.8 million in Q2 2022, and $14.5 million in Q1 2022.